PurMinds Biopharma Inc.

PURMINDS

Downloadable computer software programs for database management in the biotechnology field, namely, software for creating and visualizing in-silico models of biological systems, in particular 3D models of human and brain cells, and to generate new data to detail, predict and modulate complex molecular mechanisms and interactions with the systems and network levels; Downloadable software programs using artificial intelligence and/or machine learning in the fields of computational biology, In Silico analyses and screening, robotic Microscopy, molecular assembler, brain-computer interface, bioinformatics, and neuroinformatics; Downloadable software applications using artificial intelligence and/or machine learning for scientific and pharmaceutical product development and research purposes; downloadable software application for use in collecting and analyzing data related to neurological disorders, neurodegenerative diseases, Alzheimer's disease, and bioinformatics;Nutritional and natural dietary supplements to support mental performance and brain health, namely, supplements for neuroprotection, supplements that contain nootropics; Prescription pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Pharmaceuticals, namely, psychotropics, psychoactive compounds and non-psychoactive compounds and molecules for the neurological disorders, neurodegenerative diseases, and Alzheimer's disease;PURE MINDS;Advertising, marketing and sales of nutritional and dietary supplements, psychoactive compounds and purified psilocybin derived from natural sources and chemical synthesis;Providing medical information, consultancy and advisory services related to the treatment of neurological disorders, neurodegenerative diseases, and Alzheimer's disease; Providing information about health and wellness, namely, in the field of psychotropics, psychoactive compounds and non-psychoactive compounds and molecules; Clinical therapeutic drug monitoring for medical purposes; Screening and analytical services in the neuroscience field; Screening and analysis of neuroinformatic data and algorithms generated through the drug discovery process;Research and development of prescriptions pharmaceutical preparations for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Research and development of a portfolio of psychotropics, psychoactive compounds and non-psychoactive compounds and molecules for the prevention and treatment of neurological disorders and neurodegenerative diseases, and Alzheimer's disease; Laboratory analysis in the field of psychoactive drugs; Clinical laboratory testing and toxicology services, namely, clinical laboratory testing and toxicology services, namely, molecular and endocrinology chemical analysis; medical laboratory services; Cannabis and marijuana laboratory testing; laboratory testing of biologic substances for metals, occupational, and environmental toxins; Providing on-line non-downloadable software and machine learning for generating in-silico simulations of physiological responses for scientific, pharmaceutical research, product development, and educational purposes; Engineering and technical assistance in the nature of computer software consultation in the field of computer software that provides dynamic simulations of physiology for scientific, pharmaceutical research, product development, and educational purposes; Software design, engineering, and development services in the fields of artificial intelligence, machine learning, computational biology, In Silico analyses and screening, robotic Microscopy, molecular assembler, brain-computer interface, bioinformatics, neuroinformatic and consultation services related thereto;